Thu, November 11, 2021
Wed, November 10, 2021
Tue, November 9, 2021
Mon, November 8, 2021
Sun, November 7, 2021
Fri, November 5, 2021
Thu, November 4, 2021

Matthew Harrison Downgraded (BLUE) to Sell and Held Target at $11 on, Nov 8th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -sell-and-held-target-at-11-on-nov-8th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Downgraded "bluebird bio, Inc." (BLUE) to Sell and Held Target at $11 on, Nov 8th, 2021.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • John Newman of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Tuesday, August 10th, 2021
  • Yanan Zhu of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $25 on, Tuesday, August 10th, 2021


This is the rating of the analyst that currently disagrees with Matthew


  • Difei Yang of "Mizuho" Maintained at Strong Buy with Decreased Target to $23 on, Wednesday, September 22nd, 2021

Publication Contributing Sources